Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Live Demonstration of New RhodoLED^® XL to be Featured

WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today its sponsorship of the 17^th Edition of the Music City Symposium for Cosmetic Advances & Laser Education (SCALE), being held May 11-15, 2022 in Nashville, Tenn. As a Sponsor, Biofrontera will be hosting a booth showcasing its innovative, FDA-approved products and featuring its new RhodoLED^® XL illumination lamp used in photodynamic therapy (PDT) for treating actinic keratosis (AK). On Saturday, May 14, 2022, Dr. Michael Gold, M.D., a board-certified dermatologist, cosmetic surgeon and founder of Gold Skin Care Center in Nashville, will present a live demonstration of RhodoLED XL during the “Live Lasers and EBDs On Stage” session of the Symposium.